Underneath the Gut-Brain Axis in IBD-Evidence of the Non-Obvious

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2024 Nov 27

PMID 39596193

Authors

Lidiya V Boldyreva

Anna A Evtushenko

Maria N Lvova

Ksenia N Morozova

Elena V Kiseleva

Affiliations

Soon will be listed here.

Abstract

The gut-brain axis (GBA) plays a pivotal role in human health and wellness by orchestrating complex bidirectional regulation and influencing numerous critical processes within the body. Over the past decade, research has increasingly focused on the GBA in the context of inflammatory bowel disease (IBD). Beyond its well-documented effects on the GBA-enteric nervous system and vagus nerve dysregulation, and gut microbiota misbalance-IBD also leads to impairments in the metabolic and cellular functions: metabolic dysregulation, mitochondrial dysfunction, cationic transport, and cytoskeleton dysregulation. These systemic effects are currently underexplored in relation to the GBA; however, they are crucial for the nervous system cells' functioning. This review summarizes the studies on the particular mechanisms of metabolic dysregulation, mitochondrial dysfunction, cationic transport, and cytoskeleton impairments in IBD. Understanding the involvement of these processes in the GBA may help find new therapeutic targets and develop systemic approaches to improve the quality of life in IBD patients.

References

Wallace M . Effects of Alzheimer's disease-related beta amyloid protein fragments on enzymes metabolizing phosphoinositides in brain. Biochim Biophys Acta. 1994; 1227(3):183-7. DOI: 10.1016/0925-4439(94)90093-0. View

Serhan C . Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014; 510(7503):92-101. PMC: 4263681. DOI: 10.1038/nature13479. View

Carlsson A . Membrane bending by actin polymerization. Curr Opin Cell Biol. 2017; 50:1-7. PMC: 5911415. DOI: 10.1016/j.ceb.2017.11.007. View

Duboc H, Rajca S, Rainteau D, Benarous D, Maubert M, Quervain E . Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut. 2012; 62(4):531-9. DOI: 10.1136/gutjnl-2012-302578. View

Morgan C, Skippen A, Segui B, Ball A, Allen-Baume V, Larijani B . Phosphorylation of a distinct structural form of phosphatidylinositol transfer protein alpha at Ser166 by protein kinase C disrupts receptor-mediated phospholipase C signaling by inhibiting delivery of phosphatidylinositol to membranes. J Biol Chem. 2004; 279(45):47159-71. DOI: 10.1074/jbc.M405827200. View

Gentile J, Carrizales M, Koleske A . Control of Synapse Structure and Function by Actin and Its Regulators. Cells. 2022; 11(4). PMC: 8869895. DOI: 10.3390/cells11040603. View

Chanez-Paredes S, Montoya-Garcia A, Castro-Ochoa K, Garcia-Cordero J, Cedillo-Barron L, Shibayama M . The Arp2/3 Inhibitory Protein Arpin Is Required for Intestinal Epithelial Barrier Integrity. Front Cell Dev Biol. 2021; 9:625719. PMC: 8128147. DOI: 10.3389/fcell.2021.625719. View

Carroll M, Kuenzig M, Mack D, Otley A, Griffiths A, Kaplan G . The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD. J Can Assoc Gastroenterol. 2019; 2(Suppl 1):S49-S67. PMC: 6512244. DOI: 10.1093/jcag/gwy056. View

Fries W, Renda M, Presti M, Raso A, Orlando A, Oliva L . Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn's disease in Southern Italy. Am J Gastroenterol. 2006; 100(12):2730-6. DOI: 10.1111/j.1572-0241.2005.00325.x. View

10.

Chen L, Zhernakova D, Kurilshikov A, Andreu-Sanchez S, Wang D, Augustijn H . Influence of the microbiome, diet and genetics on inter-individual variation in the human plasma metabolome. Nat Med. 2022; 28(11):2333-2343. PMC: 9671809. DOI: 10.1038/s41591-022-02014-8. View

11.

Ulluwishewa D, Anderson R, McNabb W, Moughan P, Wells J, Roy N . Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr. 2011; 141(5):769-76. DOI: 10.3945/jn.110.135657. View

12.

Ikeda Y, Saigo N, Nagasaki Y . Direct evidence for the involvement of intestinal reactive oxygen species in the progress of depression via the gut-brain axis. Biomaterials. 2023; 295:122053. DOI: 10.1016/j.biomaterials.2023.122053. View

13.

Du Y, Chen J, Shen L, Wang B . TRP channels in inflammatory bowel disease: Potential therapeutic targets. Biochem Pharmacol. 2022; 203:115195. DOI: 10.1016/j.bcp.2022.115195. View

14.

Moon D . Calcium's Role in Orchestrating Cancer Apoptosis: Mitochondrial-Centric Perspective. Int J Mol Sci. 2023; 24(10). PMC: 10218825. DOI: 10.3390/ijms24108982. View

15.

MKoma A . Inflammatory bowel disease: an expanding global health problem. Clin Med Insights Gastroenterol. 2014; 6:33-47. PMC: 4020403. DOI: 10.4137/CGast.S12731. View

16.

Elzayat H, Mesto G, Al-Marzooq F . Unraveling the Impact of Gut and Oral Microbiome on Gut Health in Inflammatory Bowel Diseases. Nutrients. 2023; 15(15). PMC: 10421146. DOI: 10.3390/nu15153377. View

17.

Jostins L, Ripke S, Weersma R, Duerr R, McGovern D, Hui K . Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012; 491(7422):119-24. PMC: 3491803. DOI: 10.1038/nature11582. View

18.

Bonora M, Giorgi C, Pinton P . Molecular mechanisms and consequences of mitochondrial permeability transition. Nat Rev Mol Cell Biol. 2021; 23(4):266-285. DOI: 10.1038/s41580-021-00433-y. View

19.

Scuto M, Rampulla F, Reali G, Spano S, Salinaro A, Calabrese V . Hormetic Nutrition and Redox Regulation in Gut-Brain Axis Disorders. Antioxidants (Basel). 2024; 13(4). PMC: 11047582. DOI: 10.3390/antiox13040484. View

20.

Toledo Maurino J, Fonseca-Camarillo G, Furuzawa-Carballeda J, Barreto-Zuniga R, Martinez Benitez B, Granados J . TRPV Subfamily (TRPV2, TRPV3, TRPV4, TRPV5, and TRPV6) Gene and Protein Expression in Patients with Ulcerative Colitis. J Immunol Res. 2020; 2020:2906845. PMC: 7231094. DOI: 10.1155/2020/2906845. View